Novavax (NVAX), European Commission Finalize Advance Purchase Agreement for up to 200 million doses of COVID-19 Vaccine
Go back to Novavax (NVAX), European Commission Finalize Advance Purchase Agreement for up to 200 million doses of COVID-19 Vaccine| Novavax, Inc. (NASDAQ: NVAX) | Delayed: 9.81 -0.38 (3.73%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $10.19 | 52 Week High | $9.23 | |||
| Open | $10.02 | 52 Week Low | $1.16 | |||
| Day High | $10.24 | P/E | N/A | |||
| Day Low | $9.73 | EPS | $-0.30 | |||
| Volume | 2,046,098 | |||||

